STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of common stock reserved for issuance

The Company has shares reserved and available for future issuance of common stock as follows as of the periods indicated:


		June 30,		December 31,
		2026		2025
Warrants		44,313		4,313
Awards outstanding under the 2017 and 2007 Equity Incentive Plans		201,663		234,147
Awards outstanding under the 2024 Equity Incentive Plan		66,327		35,818
Shares available for future issuance under convertible debt notes		16,556,727		212,329
Shares available for future issuance under equity line-of-credit agreement		—		704
Shares available for future issuance under the 2024 Equity Incentive Plan		18,910		59,273
Shares available for future conversion of Series P and P 2 Preferred Stock		5,000,000		—
Shares authorized and available for future issuance		41,053,995		2,159,267
Total shares reserved and available for future issuance of common stock		62,941,935		2,705,851

Conversion Shares Held in Abeyance

As of June 30, 2026, 6,321,912 Conversion Shares issuable to 3i under the 3i Agreement were held in abeyance under Section 6(a) as a result of the Beneficial Ownership Limitation described in Note 5. The Company's obligation is to issue a fixed number of Conversion Shares in respect of consideration settled at Closing, and neither the 3i Agreement nor the Amended Note permits or requires settlement of that obligation in cash or other assets. Accordingly, the obligation is classified within stockholders' equity. The Conversion Shares held in abeyance are presented as a separate component of stockholders' equity of $0.9 million and are excluded from shares issued and outstanding as of June 30, 2026, as they had not been issued as of that date.